Literature DB >> 36190660

The increased cortisol levels with preserved rhythmicity in aging and its relationship with dementia and metabolic syndrome.

Antonio Martocchia1, Maurizio Gallucci2, Marianna Noale3, Stefania Maggi3, Maurizio Cassol4, Manuela Stefanelli5, Demetrio Postacchini6, Antonella Proietti5, Mario Barbagallo7, Ligia J Dominguez7, Claudio Ferri8, Giovambattista Desideri8, Lavinia Toussan5, Francesca Pastore, Giulia M Falaschi5, Giuseppe Paolisso9, Paolo Falaschi5.   

Abstract

BACKGROUND: In the aging process, the cumulative exposure to stress with increased cortisol levels is considered to be associated to the senescence itself and its related disorders. AIMS: To evaluate the role of cortisol in elderly subjects, with or without dementia, by the means of the AGICO study.
METHODS: The AGICO study enrolled patients from ten Geriatric Units in Italy in 2012-2017 (Study Director Prof Paolo Falaschi, S. Andrea Hospital of Rome). Every subject received a comprehensive geriatric assessment (including the Mini-Mental State Examination, MMSE), the neurological examination (with a computed tomography scan or magnetic resonance imaging of the brain), the assessment of the metabolic syndrome (MetS), the evaluation of the cortisol activity by two consecutive urine collections (diurnal and nocturnal).
RESULTS: The MMSE was inversely related to the standardized diurnal and nocturnal urinary cortisol levels (p < 0.025 and p < 0.01, respectively) and the age was positively related (p < 0.01 and p < 0.001, respectively). The ratio between the standardized diurnal and nocturnal urinary cortisol levels was 1.50 ± 1.2 (mean ± standard deviation) and it was not modified by the age or dementia. The standardized diurnal and nocturnal urinary cortisol levels were significantly higher in patients with dementia (MMSE < 24) (p < 0.01). In the analysis of the subgroups with MetS, the highest concentrations of diurnal and nocturnal cortisol were found in patients with both dementia and MetS (p < 0.025 and p < 0.01, respectively). DISCUSSION: The AGICO study showed that the stress response significantly and progressively increases with age.
CONCLUSION: The cortisol increase in aging is related to the presence of both dementia and metabolic syndrome.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Aging; Cortisol; Dementia; Metabolic syndrome

Year:  2022        PMID: 36190660     DOI: 10.1007/s40520-022-02262-1

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   4.481


  13 in total

Review 1.  Stress, memory, and the hippocampus: can't live with it, can't live without it.

Authors:  S J Lupien; M Lepage
Journal:  Behav Brain Res       Date:  2001-12-14       Impact factor: 3.332

2.  Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging.

Authors:  T E Seeman; B S McEwen; B H Singer; M S Albert; J W Rowe
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

3.  Urinary cortisol excretion as a predictor of incident cognitive impairment.

Authors:  Arun S Karlamangla; Burton H Singer; Joshua Chodosh; Bruce S McEwen; Teresa E Seeman
Journal:  Neurobiol Aging       Date:  2005-11-08       Impact factor: 4.673

4.  Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease.

Authors:  S Rasmuson; R Andrew; B Näsman; J R Seckl; B R Walker; T Olsson
Journal:  Biol Psychiatry       Date:  2001-03-15       Impact factor: 13.382

5.  Cortisol levels during human aging predict hippocampal atrophy and memory deficits.

Authors:  S J Lupien; M de Leon; S de Santi; A Convit; C Tarshish; N P Nair; M Thakur; B S McEwen; R L Hauger; M J Meaney
Journal:  Nat Neurosci       Date:  1998-05       Impact factor: 24.884

6.  Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol.

Authors:  E Van Cauter; R Leproult; D J Kupfer
Journal:  J Clin Endocrinol Metab       Date:  1996-07       Impact factor: 5.958

7.  Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease.

Authors:  Eva Elgh; Ann Lindqvist Astot; Markku Fagerlund; Sture Eriksson; Tommy Olsson; Birgitta Näsman
Journal:  Biol Psychiatry       Date:  2005-08-25       Impact factor: 13.382

8.  Glucocorticoid receptor gene expression is unaltered in hippocampal neurons in Alzheimer's disease.

Authors:  J R Seckl; K L French; D O'Donnell; M J Meaney; N P Nair; C M Yates; G Fink
Journal:  Brain Res Mol Brain Res       Date:  1993-05

9.  Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.

Authors:  B S Greenwald; A A Mathé; R C Mohs; M I Levy; C A Johns; K L Davis
Journal:  Am J Psychiatry       Date:  1986-04       Impact factor: 18.112

Review 10.  How stress mediators can cumulatively contribute to Alzheimer's disease An allostatic load approach.

Authors:  Tatiane Martins Matos; Juliana Nery De Souza-Talarico
Journal:  Dement Neuropsychol       Date:  2019 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.